PMID- 24828537 OWN - NLM STAT- MEDLINE DCOM- 20150526 LR - 20220316 IS - 1432-1084 (Electronic) IS - 0938-7994 (Linking) VI - 24 IP - 9 DP - 2014 Sep TI - Comparison of acquisition time and dose for late gadolinium enhancement imaging at 3.0 T in patients with chronic myocardial infarction using Gd-BOPTA. PG - 2192-200 LID - 10.1007/s00330-014-3213-y [doi] AB - OBJECTIVES: To compare contrast doses and acquisition times for late gadolinium enhancement (LGE) imaging at 3.0 T using gadobenate dimeglumine (Gd-BOPTA) in patients with chronic myocardial infarction. METHODS: Thirty-four patients with chronic myocardial infarction were randomised to 0.10, 0.15 and 0.20 mmol/kg of Gd-BOPTA. T1-weighted inversion recovery gradient echo sequences were performed at 5, 10, 15 and 20 min post-administration of contrast in a 3.0-T scanner. Scar-to-myocardium contrast-to-noise ratio (CNR), scar-to-blood CNR, scar size and image quality were assessed. RESULTS: Imaging at 5 min was associated with a lower scar-to-blood CNR in comparison to 10, 15 and 20 min at 0.10 mmol/kg, and in comparison to 15 and 20 min at 0.20 mmol/kg. At 0.10-mmol/kg, imaging at 5 min yielded smaller infarct sizes in comparison to 15 and 20 min. Finally, at 0.20-mmol/kg, imaging at 5 min was associated with poorer image quality in comparison to later times. CONCLUSIONS: In LGE imaging at 3.0 T, low doses of Gd-BOPTA perform equally well as higher doses. Early acquisition (5 min) is associated with lower infarct sizes and image quality. Studies with sufficient diagnostic quality can be obtained after 10 min using 0.10 mmol/kg Gd-BOPTA. KEY POINTS: Good performance of low Gd-BOPTA doses for LGE imaging at 3.0 T. Imaging at 5 min yields lower contrast, infarct sizes and image quality. Diagnostic quality can be obtained after 10 min using 0.10-mmol/kg Gd-BOPTA. FAU - Doltra, A AU - Doltra A AD - Department of Internal Medicine/Cardiology, German Heart Institute Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. FAU - Skorin, A AU - Skorin A FAU - Hamdan, A AU - Hamdan A FAU - Schnackenburg, B AU - Schnackenburg B FAU - Gebker, R AU - Gebker R FAU - Klein, C AU - Klein C FAU - Nagel, E AU - Nagel E FAU - Fleck, E AU - Fleck E FAU - Kelle, S AU - Kelle S LA - eng PT - Comparative Study PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20140515 PL - Germany TA - Eur Radiol JT - European radiology JID - 9114774 RN - 0 (Contrast Media) RN - 0 (Organometallic Compounds) RN - 15G12L5X8K (gadobenic acid) RN - 6HG8UB2MUY (Meglumine) RN - AU0V1LM3JT (Gadolinium) SB - IM MH - Aged MH - Aged, 80 and over MH - Chronic Disease MH - Contrast Media/administration & dosage MH - Dose-Response Relationship, Drug MH - Electrocardiography MH - Female MH - Gadolinium MH - Humans MH - Image Enhancement/*methods MH - Magnetic Resonance Imaging, Cine/*methods MH - Male MH - Meglumine/administration & dosage/*analogs & derivatives MH - Middle Aged MH - Myocardial Infarction/*diagnosis MH - Myocardium/*pathology MH - *Organometallic Compounds/administration & dosage MH - ROC Curve MH - Severity of Illness Index EDAT- 2014/05/16 06:00 MHDA- 2015/05/27 06:00 CRDT- 2014/05/16 06:00 PHST- 2014/01/05 00:00 [received] PHST- 2014/04/30 00:00 [accepted] PHST- 2014/03/13 00:00 [revised] PHST- 2014/05/16 06:00 [entrez] PHST- 2014/05/16 06:00 [pubmed] PHST- 2015/05/27 06:00 [medline] AID - 10.1007/s00330-014-3213-y [doi] PST - ppublish SO - Eur Radiol. 2014 Sep;24(9):2192-200. doi: 10.1007/s00330-014-3213-y. Epub 2014 May 15.